Heptares Therapeutics Ltd has announced the grant of a core patent in the UK on its technology for generating stabilized GPCRs (StaRs) and a series of UK patents on specific StaRs and their use in drug screening (GB2456235, GB2456237, GB2456904 and GB2456236).
20 November, 2009
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010.
19 November, 2009
One difficulty with fighting cancer cells is that they are similar in many respects to the body’s stem cells. By focusing on the differences between the two cell types, researchers have found a new way of tackling colon cancer.
17 November, 2009